TEAS RF New Application
SLTX
Sigilon Therapeutics, Inc.
Trademark/Service Mark Application, Principal Register
| Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006) |
| OMB No. 0651-0009 (Exp 02/28/2021) |
Trademark/Service Mark Application, Principal Register
| Serial Number: 88197578 |
| Filing Date: 11/16/2018 |
The table below presents the data as entered.
| Input Field |
Entered |
| SERIAL NUMBER | 88197578 |
|---|---|
| MARK INFORMATION | |
| *MARK | SLTX |
| STANDARD CHARACTERS | YES |
| USPTO-GENERATED IMAGE | YES |
| LITERAL ELEMENT | SLTX |
| MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
| REGISTER | Principal |
| APPLICANT INFORMATION | |
| *OWNER OF MARK | Sigilon Therapeutics, Inc. |
| *STREET | 100 Binney Street, Suite 600 |
| *CITY | Cambridge |
| *STATE (Required for U.S. applicants) |
Massachusetts |
| *COUNTRY | United States |
| *ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
02142 |
| LEGAL ENTITY INFORMATION | |
| TYPE | corporation |
| STATE/COUNTRY OF INCORPORATION | Delaware |
| GOODS AND/OR SERVICES AND BASIS INFORMATION | |
| INTERNATIONAL CLASS | 001 |
| *IDENTIFICATION | Chemical agents for coating of medical devices and medical materials; reagents for research purposes; reagents for scientific or medical research use |
| FILING BASIS | SECTION 1(b) |
| INTERNATIONAL CLASS | 005 |
| *IDENTIFICATION | Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for modulating immune response; chemical agents for pharmaceutical or medical purposes, namely, pharmaceutical agents for modulating immune response; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, inflammation, cancer or infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; chemical agents, namely, drug delivery agents in the form of coatings that facilitate the delivery of pharmaceutical agents and cells |
| FILING BASIS | SECTION 1(b) |
| ATTORNEY INFORMATION | |
| NAME | Ann Lamport Hammitte |
| ATTORNEY DOCKET NUMBER | S2225-2001 |
| FIRM NAME | LANDO & ANASTASI, LLP |
| STREET | One Main Street |
| CITY | Cambridge |
| STATE | Massachusetts |
| COUNTRY | United States |
| ZIP/POSTAL CODE | 02142 |
| PHONE | 617-395-7019 |
| EMAIL ADDRESS | alhtrademarks@lalaw.com |
| AUTHORIZED TO COMMUNICATE VIA EMAIL | Yes |
| OTHER APPOINTED ATTORNEY | the practitioners associated with customer number 37462 |
| CORRESPONDENCE INFORMATION | |
| NAME | Ann Lamport Hammitte |
| FIRM NAME | LANDO & ANASTASI, LLP |
| STREET | One Main Street |
| CITY | Cambridge |
| STATE | Massachusetts |
| COUNTRY | United States |
| ZIP/POSTAL CODE | 02142 |
| PHONE | 617-395-7019 |
| *EMAIL ADDRESS | alhtrademarks@lalaw.com |
| *AUTHORIZED TO COMMUNICATE VIA EMAIL | Yes |
| FEE INFORMATION | |
| APPLICATION FILING OPTION | TEAS RF |
| NUMBER OF CLASSES | 2 |
| APPLICATION FOR REGISTRATION PER CLASS | 275 |
| *TOTAL FEE DUE | 550 |
| *TOTAL FEE PAID | 550 |
| SIGNATURE INFORMATION | |
| ORIGINAL PDF FILE | hw_389711398-173127230_._App_and_POA_Sigilon.SLTX.pdf |
| CONVERTED PDF FILE(S) (4 pages) |
\\TICRS\EXPORT17\IMAGEOUT17\881\975\88197578\xml1\RFA0003.JPG |
| \\TICRS\EXPORT17\IMAGEOUT17\881\975\88197578\xml1\RFA0004.JPG | |
| \\TICRS\EXPORT17\IMAGEOUT17\881\975\88197578\xml1\RFA0005.JPG | |
| \\TICRS\EXPORT17\IMAGEOUT17\881\975\88197578\xml1\RFA0006.JPG | |
| SIGNATORY'S NAME | Rogerio Vivaldi, M.D., M.B.A. |
| SIGNATORY'S POSITION | CEO |
| Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006) |
| OMB No. 0651-0009 (Exp 02/28/2021) |
Trademark/Service Mark Application, Principal Register
| Serial Number: 88197578 |
| Filing Date: 11/16/2018 |
To the Commissioner for Trademarks:
MARK: SLTX (Standard Characters, see below )
The literal element of the mark consists of SLTX.
The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Sigilon Therapeutics, Inc., a corporation of Delaware, having an address of
100 Binney Street, Suite 600
Cambridge, Massachusetts 02142
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:
International Class 001: Chemical agents for coating of medical devices and medical materials; reagents for research purposes; reagents for scientific or medical research use
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 005: Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for modulating immune response; chemical agents for pharmaceutical or medical purposes, namely, pharmaceutical agents for modulating immune response; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, inflammation, cancer or infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; chemical agents, namely, drug delivery agents in the form of coatings that facilitate the delivery of pharmaceutical agents and cells
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The applicant's current Attorney Information:
Ann Lamport Hammitte and the practitioners associated with customer number 37462 of LANDO & ANASTASI, LLP One Main Street
Cambridge, Massachusetts 02142
United States
617-395-7019(phone)
alhtrademarks@lalaw.com (authorized)
The attorney docket/reference number is S2225-2001.
| The applicant's current Correspondence Information: |
| Ann Lamport Hammitte |
| LANDO & ANASTASI, LLP |
| One Main Street |
| Cambridge, Massachusetts 02142 |
| 617-395-7019(phone) |
| alhtrademarks@lalaw.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services. |
A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
The attached signature image file:
\\TICRS\EXPORT17\IMAGEOUT17\881\975\88197578\xml1\RFA0003.JPG
Signatory's Name: Rogerio Vivaldi, M.D., M.B.A.
Signatory's Position: CEO
Payment Sale Number: 88197578
Payment Accounting Date: 11/19/2018
Serial Number: 88197578
Internet Transmission Date: Fri Nov 16 17:34:12 EST 2018
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XX-20181116173412133
657-88197578-610aa874e74f5ca84139eb73688
80b9168bb47d6ef99e2d82e72bed2d0eccbb3af-
DA-4581-20181116173127230633